Clinical Trials Directory

Trials / Unknown

UnknownNCT03494829

Physical Activity, Motor Competence, Pulmonary Function, and Quality of Life in Children With Severe Spinal Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
1 Year – 20 Years
Healthy volunteers
Not accepted

Summary

Observation study about physical activity, motor competence, pulmonary function, and health related quality of life in children, surgically treated for early onset scoliosis

Detailed description

Early Onset Scoliosis (EOS) defines patients who develop deformities of the spine and/or thorax in the embryologic development or in the early childhood. The exact prevalence of EOS in Norway is unknown, but it is assumed to be approximately 200-300 new EOS patients every year. EOS is a severe condition, whereby some of the most common and also most severe consequences of the deformity are severe pulmonary problems. The patients may require extensive orthopedic treatment from early childhood and until maturity to avoid serious consequences with severe pulmonary problems and shortening of life. EOS' secondary problems, including severe consequences on the pulmonary function might contribute to enhanced inactivity. Inactivity contributes to further negative impact on development of the musculoskeletal system, motor competence and pulmonary function. Considering the severity of EOS and children's reduced life expectancy, it is extremely important that EOS children achieve the favorable impact of physical activity during their growth. Insufficient level of activity might worsen the prognosis, thus counteracting the treatment's ambitions. The investigator's aim is to extend the knowledge about level of activity, motor competence, pulmonary function, and health related quality of life in Norwegian children, surgically treated for EOS.

Conditions

Timeline

Start date
2016-11-01
Primary completion
2022-01-01
Completion
2022-12-01
First posted
2018-04-11
Last updated
2021-09-20

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03494829. Inclusion in this directory is not an endorsement.